Publications by authors named "Russell Wada"

Claim this Profile
E
Exposure-response analysis of the efficacy and safety of esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker, in hypertensive patients with or without diabetic kidney disease.
Kazutaka Yoshihara, Masato Fukae, Helen Kastrissios, Russell Wada, Takako Shimizu

Drug Metab Pharmacokinet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of esaxerenone, a novel non-steroidal mineralocorticoid receptor blocker, in patients with essential hypertension, patients with diabetic nephropathy, and healthy volunteers.
Kazutaka Yoshihara, Masato Fukae, Helen Kastrissios, Russell Wada, Takako Shimizu

Drug Metab Pharmacokinet· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic analysis of sparsentan in healthy volunteers and patients with focal segmental glomerulosclerosis.
Russell Wada, Huub Jan Kleijn, Lu Zhang, Shang-Chiung Chen

CPT Pharmacometrics Syst Pharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response characterisation of tildrakizumab in chronic plaque psoriasis: Pooled analysis of 3 randomised controlled trials.
Thomas Kerbusch, Hanbin Li, Russell Wada, Petra M Jauslin, Larissa Wenning

Br J Clin Pharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin), a HER2-targeted monoclonal antibody, in patients with a variety of solid tumors.
Angelica L Quartino, Hanbin Li, Whitney P Kirschbrown, Ranvir Mangat, D Russell Wada

Cancer Chemother Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic Properties of a Sufentanil Sublingual Tablet Intended to Treat Acute Pain.
Dennis M Fisher, Peter Chang, D Russell Wada, Albert Dahan, Pamela P Palmer

Anesthesiology· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane.
Chunze Li, Bei Wang, Shang-Chiung Chen, Russell Wada, Dan Lu

Cancer Chemother Pharmacol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and exposure-response analyses of pertuzumab in combination with trastuzumab and docetaxel during neoadjuvant treatment of HER2+ early breast cancer.
Angelica L Quartino, Hanbin Li, Jin Y Jin, D Russell Wada, Mark C Benyunes

Cancer Chemother Pharmacol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic and exposure-response analysis for trastuzumab administered using a subcutaneous "manual syringe" injection or intravenously in women with HER2-positive early breast cancer.
Angelica L Quartino, Carina Hillenbach, Jing Li, Hanbin Li, Russell D Wada

Cancer Chemother Pharmacol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9.
Nageshwar R Budha, Maya Leabman, Jin Y Jin, D Russell Wada, Amos Baruch

AAPS J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling and simulation of orlistat to predict weight loss and weight maintenance in obesity patients.
Kiyohiko Nakai, Russell Wada, Satofumi Iida, Takehiko Kawanishi, Yoshiaki Matsumoto

Drug Metab Pharmacokinet· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors.
Amit Garg, Angelica Quartino, Jing Li, Jin Jin, D Russell Wada

Cancer Chemother Pharmacol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys.
Murielle M Véniant, Renee Komorowski, Ping Chen, Shanaka Stanislaus, Katherine Winters, Russell Wada

Endocrinology· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis.
M Soledad Cepeda, Jesse A Berlin, C Yuying Gao, Frank Wiegand, D Russell Wada

Pain Med· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the onset and offset of dental pain relief by ibuprofen.
Hanbin Li, Jaap Mandema, Russell Wada, Shyamalie Jayawardena, Paul Desjardins

J Clin Pharmacol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain relief model for a COX-2 inhibitor in patients with postoperative dental pain.
Shashank Rohatagi, Helen Kastrissios, Kunihiro Sasahara, Kenneth Truitt, James B Moberly, Russell Wada

Br J Clin Pharmacol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of olmesartan following oral administration of its prodrug, olmesartan medoxomil: in healthy volunteers and hypertensive patients.
Kazutaka Yoshihara, Yuying Gao, Hiroshi Shiga, D Russell Wada, Masafumi Hisaoka

Clin Pharmacokinet· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enriched analgesic efficacy studies: an assessment by clinical trial simulation.
Hendrikus J M Lemmens, D Russell Wada, Catherine Munera, Ahmed Eltahtawy, Donald R Stanski

Contemp Clin Trials· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining drug-disease and economic modelling to inform drug development decisions.
Bill Poland, Russell Wada

Drug Discov Today· November 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis